CL2012000487A1 - Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales. - Google Patents

Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.

Info

Publication number
CL2012000487A1
CL2012000487A1 CL2012000487A CL2012000487A CL2012000487A1 CL 2012000487 A1 CL2012000487 A1 CL 2012000487A1 CL 2012000487 A CL2012000487 A CL 2012000487A CL 2012000487 A CL2012000487 A CL 2012000487A CL 2012000487 A1 CL2012000487 A1 CL 2012000487A1
Authority
CL
Chile
Prior art keywords
disorders
treat
composition
bifidobacterium longum
prevent functional
Prior art date
Application number
CL2012000487A
Other languages
English (en)
Spanish (es)
Inventor
Premysl Bercik
Stephen Michael Collins
Peter Mclean
De Gonda Gabriela Bergonzelli
De Bercik Elena Verdu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000487(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2012000487A1 publication Critical patent/CL2012000487A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL2012000487A 2009-08-25 2012-02-24 Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales. CL2012000487A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09168590.9A EP2289527B1 (en) 2009-08-25 2009-08-25 Bifidobacterium longum and functional GI disorders

Publications (1)

Publication Number Publication Date
CL2012000487A1 true CL2012000487A1 (es) 2012-08-31

Family

ID=41508246

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000487A CL2012000487A1 (es) 2009-08-25 2012-02-24 Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.

Country Status (17)

Country Link
US (3) US10028981B2 (OSRAM)
EP (2) EP2289527B1 (OSRAM)
JP (4) JP2013503130A (OSRAM)
CN (2) CN106072658A (OSRAM)
AU (1) AU2010288546B2 (OSRAM)
BR (1) BR112012004046B1 (OSRAM)
CA (1) CA2772163C (OSRAM)
CL (1) CL2012000487A1 (OSRAM)
DK (1) DK2289527T3 (OSRAM)
ES (1) ES2664828T3 (OSRAM)
IN (1) IN2012DN01638A (OSRAM)
MX (1) MX2012002402A (OSRAM)
RU (1) RU2012111253A (OSRAM)
SG (1) SG178499A1 (OSRAM)
TR (1) TR201807143T4 (OSRAM)
WO (1) WO2011023689A1 (OSRAM)
ZA (1) ZA201202155B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
TR201807143T4 (tr) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
CN104780932A (zh) 2012-02-29 2015-07-15 伊西康内外科公司 微生物区系的组合物及与其相关的方法
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
JP6637885B2 (ja) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
BR112017023636B1 (pt) 2015-06-11 2021-11-03 Société des Produits Nestlé S.A. Composição oral
CA2994347A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances
CA2994345A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms
CN107980002A (zh) * 2015-08-31 2018-05-01 雀巢产品技术援助有限公司 使用长双岐杆菌优化母乳喂养的方法和组合物
PL3368046T3 (pl) 2015-10-28 2022-11-28 Glycom A/S Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
JP6353478B2 (ja) * 2016-03-28 2018-07-04 日清食品ホールディングス株式会社 セロトニン分泌促進能力を有するビフィズス菌
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法
CN106579414A (zh) * 2016-12-26 2017-04-26 北京康比特体育科技股份有限公司 一种缓解运动性腹泻的组合物
EP3589726A1 (en) 2017-02-28 2020-01-08 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
RU2768030C2 (ru) * 2017-02-28 2022-03-23 Элиментари Хелт Лимитед Bifidobacterium longum, способный благоприятно модулировать иммунный ответ на респираторную вирусную инфекцию
MX2019013143A (es) * 2017-05-05 2020-07-14 Nestle Sa Tratamiento de colicos infantiles.
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
JP7285096B2 (ja) 2018-03-28 2023-06-01 森永乳業株式会社 ストレス緩和用組成物並びに該ストレス緩和用組成物を用いた医薬品組成物及び飲食品組成物
WO2020018949A2 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
BR112021025362A2 (pt) * 2019-07-01 2022-02-01 Nestle Sa Produção de serpina
JP2021014421A (ja) * 2019-07-11 2021-02-12 日清ファルマ株式会社 Ｑｏｌ改善剤
JP2021014422A (ja) * 2019-07-11 2021-02-12 日清ファルマ株式会社 便性改善剤
CN111187734A (zh) * 2019-12-25 2020-05-22 生合生物科技（扬州）有限公司 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用
EP4153200A1 (en) * 2020-05-20 2023-03-29 Société des Produits Nestlé S.A. Improvement of insoluble fibre fermentability and short chain fatty acid production by bifidobacterium longum

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637297A5 (fr) 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
DE10008279A1 (de) * 2000-02-23 2001-08-30 Meggle Gmbh Milchzucker enthaltende Zusammensetzung
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
PE20030284A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
WO2003020048A1 (en) * 2001-08-31 2003-03-13 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
JP2004262773A (ja) 2003-02-17 2004-09-24 Ryoshoku Kenkyukai 免疫機能改善を目的としたビフィズス菌製剤
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
RU2346448C2 (ru) * 2003-06-23 2009-02-20 Нестек С.А. Смесь для детей первых месяцев жизни или старше
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US8134942B2 (en) * 2005-08-24 2012-03-13 Avaak, Inc. Communication protocol for low-power network applications and a network of sensors using the same
WO2007054208A1 (en) * 2005-11-14 2007-05-18 Unilever N.V. Edible product containing ginseng polysaccharides and beneficial bacteria
JP2007169200A (ja) * 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd インフルエンザ感染予防のための医薬及び飲食品
PL1986669T3 (pl) * 2006-02-15 2012-09-28 Nestec Sa Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
ES2553636T3 (es) 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
EP1961308A1 (en) * 2007-02-21 2008-08-27 Nestec S.A. Nutritionally balanced frozen dessert
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CN101939000A (zh) * 2007-12-17 2011-01-05 佛罗里达大学研究基金会有限公司 用于治疗病理性眼部血管增生的物质和方法
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
TR201807143T4 (tr) 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
CN112074193A (zh) * 2018-01-29 2020-12-11 精密生物集团有限公司 一种用于预防和治疗肠易激综合征的组合产品

Also Published As

Publication number Publication date
JP2020183385A (ja) 2020-11-12
CA2772163C (en) 2017-11-07
JP2013503130A (ja) 2013-01-31
IN2012DN01638A (OSRAM) 2015-06-05
ES2664828T3 (es) 2018-04-23
RU2012111253A (ru) 2013-10-10
US11957720B2 (en) 2024-04-16
EP2289527A1 (en) 2011-03-02
EP2289527B1 (en) 2018-02-21
TR201807143T4 (tr) 2018-06-21
AU2010288546B2 (en) 2015-08-20
CN106072658A (zh) 2016-11-09
WO2011023689A1 (en) 2011-03-03
BR112012004046A2 (pt) 2017-05-30
US20120230956A1 (en) 2012-09-13
JP7096652B6 (ja) 2022-08-01
EP2470188A1 (en) 2012-07-04
CA2772163A1 (en) 2011-03-03
JP2018048112A (ja) 2018-03-29
US11452745B2 (en) 2022-09-27
JP7096652B2 (ja) 2022-07-06
JP2016074682A (ja) 2016-05-12
US20220280576A1 (en) 2022-09-08
US20190134104A1 (en) 2019-05-09
AU2010288546A1 (en) 2012-03-22
ZA201202155B (en) 2014-09-25
MX2012002402A (es) 2012-04-02
DK2289527T3 (en) 2018-04-23
US10028981B2 (en) 2018-07-24
CN102573863A (zh) 2012-07-11
BR112012004046B1 (pt) 2021-02-17
SG178499A1 (en) 2012-04-27

Similar Documents

Publication Publication Date Title
CL2012000487A1 (es) Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.
CL2009000905A1 (es) Composicion comestible que comprende bifidobacterium longum atcc baa-999; y su uso para tratar o prevenir la ansiedad y/o desordenes relacionados con ansiedad.
SMT201500280B (it) Nuove composizioni per prevenire e/o trattare disturbi da accumulo lisosomiale
HUE046610T2 (hu) Probiotikus készítmény kutyák gyomor-bélrendszeri rendellenességeinek megelõzésére vagy kezelésére
BR112012005533A2 (pt) material não viável derivado de probiótijco para prevenção e tratamento de alegria
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
HRP20160737T1 (hr) Anti-her3-protutijela i njihove uporabe
BR112012004149A2 (pt) terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
BRPI1006147A2 (pt) composições que compreendem componentes probióticos e prebióticos e sais mineirais, com lactoferrina
HRP20160598T1 (hr) Bakterijski sastavi za prevenciju i liječenje degenerativne bolesti
BRPI0922486A2 (pt) microcápsulas e suas respectivas utilizações
DOP2012000115A (es) Metodos para preparar y usar composiciones que comprenden flavonoides
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
DK2318513T3 (da) Ny probiotisk bifidobacterium longum
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BRPI1013065A2 (pt) artigo para fumar com elemento de restrição de fluxo aperfeiçoado
EP2249854A4 (en) IMPROVED TREATMENT AND PROPHYLAXIS
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
EP2441646A4 (en) SUPPORT AND STROLLER FOR BABY
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0916043A2 (pt) composição farmacêutica e alimento funcional para prevenir ou tratar câncer
PT2501234T (pt) Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina